CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers.
Teh SSK, Bowland K, Bennett A, Halper-Stromberg E, Skaist A, Tang J, Cai F, Macoretta A, Liang H, Kamiyama H, Wheelan S, Lin MT, Hruban RH, Scharpf RB, Roberts NJ, Eshleman JR.
Teh SSK, et al.
bioRxiv [Preprint]. 2023 Oct 10:2023.04.15.537042. doi: 10.1101/2023.04.15.537042.
bioRxiv. 2023.
PMID: 37131822
Free PMC article.
Preprint.